Combining Biomarkers and Imaging for Short‐Term Assessment of Cardiovascular Disease Risk in Apparently Healthy Adults

Combining Biomarkers and Imaging for Short‐Term Assessment of Cardiovascular Disease Risk in Apparently Healthy Adults

Background Current strategies for cardiovascular disease (CVD) risk assessment focus on 10‐year or longer timeframes. Shorter‐term CVD risk is also clinically relevant, particularly for high‐risk occupations, but is under‐investigated. Methods and Results We pooled data from participants in the ARIC...

Full description

Bibliographic Details
Main Authors:	Maria Odette Gore, Colby R. Ayers, Amit Khera, Christopher R. deFilippi, Thomas J. Wang, Stephen L. Seliger, Vijay Nambi, Elizabeth Selvin, Jarett D. Berry, W. Gregory Hundley, Matthew Budoff, Philip Greenland, Mark H. Drazner, Christie M. Ballantyne, Benjamin D. Levine, James A. de Lemos
Format:	Article
Language:	English
Published:	Wiley 2020-08-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	carotid intima‐media thickness coronary artery calcium high‐sensitivity cardiac troponin T high‐sensitivity C‐reactive protein N‐terminal pro B‐type natriuretic peptide plaque
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.119.015410

Similar Items

Point: high-sensitive troponin assays – a valuable tool for astute physicians
by: Mario Plebani, et al.
Published: (2013-10-01)

The importance of modern high - sensitivity troponin tests in the diagnosis of myocardial infarction without ST-segment elevation
by: O V Abaturova, et al.
Published: (2019-09-01)

High sensitivity troponin T and I reflect mitral annular plane systolic excursion being assessed by cardiac magnetic resonance imaging
by: Michèle Natale, et al.
Published: (2017-10-01)

Can the Addition of NT-proBNP and Glucose Measurements Improve the Prognostication of High-Sensitivity Cardiac Troponin Measurements for Patients with Suspected Acute Coronary Syndrome?
by: Peter A. Kavsak, et al.
Published: (2021-09-01)

Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery Disease
by: Julius Nikorowitsch, et al.
Published: (2020-03-01)

Counterpoint: highly-sensitive troponin immunoassays in the emergency department
by: Giuseppe Lippi, et al.
Published: (2013-09-01)

Utility of Heart-type Fatty Acid Binding Protein as a New Biochemical Marker for the Early Diagnosis of Acute Coronary Syndrome
by: Bhakti N. Gami, et al.
Published: (2015-01-01)

Cardiac Biomarkers and Subsequent Risk of Hospitalization With Bleeding in the Community: Atherosclerosis Risk in Communities Study
by: Lena Mathews, et al.
Published: (2020-03-01)

Joint effect of highly-sensitive cardiac troponin T and ankle-brachial index on incident cardiovascular events: The MESA and CHS
by: Yacob G. Tedla, et al.
Published: (2023-03-01)

Circulating Biomarkers for Monitoring Chemotherapy-Induced Cardiotoxicity in Children
by: Luigia Meo, et al.
Published: (2023-11-01)

Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy
by: Wang Yongchao, et al.
Published: (2023-11-01)

Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study
by: Yu Jia, et al.
Published: (2022-04-01)

Relationship between high‐sensitivity cardiac troponin T, B‐type natriuretic peptide, and physical function in patients with heart failure
by: Kensuke Ueno, et al.
Published: (2021-12-01)

Comparative outcome analysis of stable mildly elevated high sensitivity troponin T in patients presenting with chest pain. A single-center retrospective cohort study
by: Osama Mahmoud, et al.
Published: (2020-10-01)

Orthostatic Hypotension and Risk of Clinical and Subclinical Cardiovascular Disease in Middle‐Aged Adults
by: Stephen P. Juraschek, et al.
Published: (2018-05-01)

Four high sensitivity troponin assays and mortality in US adults with cardiovascular disease: The national health and nutrition examination survey, 1999–2004
by: John W. McEvoy, et al.
Published: (2024-03-01)

Associations of High‐Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT
by: Simon B. Ascher, et al.
Published: (2022-03-01)

Diagnostic and prognostic information provided by a high sensitivity assay for cardiac troponin T
by: Jarausch Jochen
Published: (2010-01-01)

Contemporary Biomarker Strategies for Patients with Chest Pain
by: Stephen Boone, et al.
Published: (2022-04-01)

Comparative analysis of high-sensitivity cardiac troponin I and T for their association with coronary computed tomography-assessed calcium scoring represented by the Agatston score
by: Jonas Rusnak, et al.
Published: (2017-11-01)

The Role of Cardiac Biomarkers in the Diagnosis of Hypertensive Emergency
by: Mohammed A. Talle, et al.
Published: (2023-04-01)

Perioperative changes in cardiac biomarkers in juvenile cats during neutering
by: Keisuke Konishi, et al.
Published: (2022-10-01)

High-Sensitivity Troponin T Testing: Consequences on Daily Clinical Practice and Effects on Diagnosis of Myocardial Infarction
by: Christian Frédéric Zachoval, et al.
Published: (2020-03-01)

Single‐Molecule Counting of High‐Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study
by: Cian P. McCarthy, et al.
Published: (2018-03-01)

High-sensitivity troponins after a standardized 2-hour treadmill run
by: Broz Pavel, et al.
Published: (2018-01-01)

High-sensitive cardiac troponin: friend or foe?
by: Swiss Medical Weekly
Published: (2011-05-01)

Outcomes in ED patients with non‐specific ECG findings and low high‐sensitivity troponin
by: Lamees M. Alshaikh, et al.
Published: (2022-12-01)

25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
by: Erin D. Michos, et al.
Published: (2016-10-01)

Highly Sensitive Cardiac Troponins: The Evidence Behind Sex‐Specific Cutoffs
by: Prerana M. Bhatia, et al.
Published: (2020-05-01)

Cardiotoxicity as a Possible Side Effect of Statins
by: Aleksey Chaulin
Published: (2023-01-01)

Biomarkers in cardiovascular medicine: towards precision medicine
by: Danielle Menosi Gualandro, et al.
Published: (2019-10-01)

Role of high-sensitivity troponin T as a sensitive biomarker for postoperative myocardial infarction and outcome after isolated coronary artery bypass grafting surgery
by: Ahmed A Faragalla, et al.
Published: (2019-01-01)

Distribution and prognostic value of high-sensitivity cardiac troponin T and I across glycemic status: a population-based study
by: Jiajun Zhang, et al.
Published: (2024-02-01)

Clinical Biochemistry of Serum Troponin
by: Ilhan Gokhan, et al.
Published: (2024-02-01)

High-Sensitivity Cardiac Troponin Impact on the Differential Diagnosis of Non-ST Segment Elevation Coronary Syndromes—Is It Helping?
by: Kristina Šulskutė, et al.
Published: (2022-08-01)

Is high sensitive-troponin I a reliable biomarker for cardiac injury in methadone toxicity? A prospective cross-sectional study
by: Hasan Shemirani, et al.
Published: (2022-03-01)

The diagnostic utility of High-Sensitivity Cardiac Troponin T in acute coronary syndrome
by: Manal Mohsen, et al.
Published: (2016-03-01)

High-sensitive troponin-T as a predictive outcome factor in COVID-19 hospitalised patients: Analysis after one-year follow-up
by: Stojanović Darko, et al.
Published: (2021-01-01)

Homocysteine is associated with plasma high-sensitivity cardiac troponin T levels in a community-dwelling population
by: Cao R, et al.
Published: (2013-12-01)

Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity?
by: A. M. Chaulin, et al.
Published: (2023-05-01)